LONDON, May 19, 2015 /PRNewswire/ -- Implantable infusion pumps are intended to provide long-term continuous or intermittent drug infusion; possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, and epidural. They are the least utilized and most complex of infusion pumps. These pumps are typically labeled for specific drugs, dosages, and routes of administration and require a high level of sophistication in the technology to run these pumps. For this reason, there are few pumps approved by regulatory agencies around the world and unit costs for these pumps remain high.
Implantable infusion pumps are most commonly used to administer:
Chemotherapy for liver cancer patients
Anti-spasmodic drugs for those with severe spasticity
Opioid drugs for treatment of chronic intractable pain
Implantable Infusion Pumps: World Market Analysis analyzes the current and potential world market for implantable infusion pumps, with market forecasts to 2018. The report includes discussion of:
Key products, manufacturers and recent developments, including MRI compatibility
The market for implantable infusion pumps is limited to a handful of providers. The companies discussed in the report are:
Flowonix Medical, Inc.
Codman & Shurtleff
I-Flow / Halyard Health
Estimates are based on a combination of the estimated number of users worldwide and sales from competitors' business segments offering these pumps. The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.
Download the full report: https://www.reportbuyer.com/product/2861344/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48